tangeretin has been researched along with Experimental Mammary Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gul, HF; Ilhan, N; Kuloglu, T; Ozercan, IH | 1 |
| Lakshmi, A; Subramanian, S | 1 |
| Lakshmi, A; Subramanian, SP | 1 |
| Arivazhagan, L; Sorimuthu Pillai, S | 1 |
| Baskaran, K; Ilakkia, A; Periyasamy, K; Sakthisekaran, D; Selvaraj, S; Vanitha, K | 1 |
| Boterberg, T; Bracke, ME; Depypere, HT; Mareel, MM; Nuytinck, M; Serreyn, R; Van Marck, VL; Vanluchene, E; Vennekens, KM | 1 |
| Boterberg, T; Bracke, ME; Depypere, HT; Mareel, MM; Nuytinck, M; Serreyn, R; Vennekens, K | 1 |
7 other study(ies) available for tangeretin and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
The combined effect of pomegranate extract and tangeretin on the DMBA-induced breast cancer model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; bcl-2-Associated X Protein; Carcinogens; Chemoprevention; Drug Combinations; Estrogen Receptor alpha; Female; Flavones; Ki-67 Antigen; Mammary Neoplasms, Experimental; NF-kappa B; Plant Extracts; Pomegranate; Rats; Rats, Sprague-Dawley; Tumor Suppressor Protein p53 | 2021 |
Chemotherapeutic effect of tangeretin, a polymethoxylated flavone studied in 7, 12-dimethylbenz(a)anthracene induced mammary carcinoma in experimental rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; alpha-Fetoproteins; Animals; Antineoplastic Agents, Phytogenic; Carcinoembryonic Antigen; Carcinoma, Ductal, Breast; Drug Screening Assays, Antitumor; Female; Flavones; Liver; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Metabolic Detoxication, Phase I; Mucin-1; Oxidative Stress; Rats; Rats, Wistar; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Thiobarbituric Acid Reactive Substances; Tumor Burden | 2014 |
Tangeretin ameliorates oxidative stress in the renal tissues of rats with experimental breast cancer induced by 7,12-dimethylbenz[a]anthracene.
Topics: Animals; Antioxidants; Benz(a)Anthracenes; Carcinogens; Cytokines; Female; Flavones; Hydroxyl Radical; Kidney; Mammary Neoplasms, Experimental; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Superoxides; Up-Regulation | 2014 |
Tangeretin, a citrus pentamethoxyflavone, exerts cytostatic effect via p53/p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Carcinogens; Female; Flavones; Gonadal Steroid Hormones; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Polymerase Chain Reaction; Proto-Oncogene Proteins p21(ras); Rats; Rats, Wistar; Tumor Suppressor Protein p53; Up-Regulation | 2014 |
Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague-Dawley rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Biomarkers; Body Weight; Carcinoembryonic Antigen; Carcinogens; Dose-Response Relationship, Drug; Female; Flavones; Mammary Neoplasms, Experimental; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2015 |
Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Synergism; Female; Flavones; Flavonoids; Gene Expression Regulation, Neoplastic; Killer Cells, Natural; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Plant Extracts; Tamoxifen; Tumor Cells, Cultured | 1999 |
Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Female; Flavones; Flavonoids; Food-Drug Interactions; Mammary Neoplasms, Experimental; Mice; Tamoxifen | 2000 |